DAIC

NOVEMBER 8, 2024

tim.hodson Fri, 11/08/2024 - 09:57 Nov. 1, 2024 — Recor Medical, Inc. Centers for Medicare & Medicaid Services (CMS) have granted the company’s Paradise Ultrasound Renal Denervation system a Transitional Pass-through (TPT) payment. and its parent company, Otsuka Medical Devices Co. recently announced U.S.

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

CardiacWire

APRIL 10, 2024

The ACC 2024 meeting is now complete, after over 17,000 cardiology professionals converged in Atlanta to witness cardiovascular medicine evolve in front of their eyes. The post Cardiac Wire’s Top 8 Takeaways from ACC 2024 appeared first on Cardiac Wire.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 16:03 April 23, 2024 — CDL Nuclear Technologies , a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. CDL provides this service in compliance with all healthcare regulations.

Technology 52

Technology Innovation Medicare Hospital 52

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 3 “We very much appreciate FDA’s breakthrough designation recognition of the bioadaptor technology,” continued Sirhan. Food and Drug Administration (FDA). of the U.S.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Circulation: Cardiovascular Imaging

MARCH 13, 2025

The use of fractional flow reserve by CT per 100 000 Medicare enrollees increased by >16-fold from 2018 (the first year covered) to 2022, and cardiac amyloidosis pyrophosphate scintigraphy studies increased 4-fold from 2011 to 2022 (0.17% to 0.68%). of cardiac testing use in 2011 and 67.7% to 1.7%), stress echocardiography (3.6%

Medicare 40

Medicare Exercise Cardiovascular Imaging Technology 40

DAIC

MARCH 27, 2025

In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. Dorbala, S., Di Carli,M. Bateman, T.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

DAIC

MARCH 20, 2024

milla1cf Wed, 03/20/2024 - 18:50 March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). CLTI is associated with high rates of amputation and mortality as well as high care costs.1

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

MARCH 7, 2024

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

DAIC

MAY 8, 2024

2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. 2024, [link]. For more information: www.heartflow.com References 1 Krievins, Dainis K., Journal of Vascular Surgery, Mar.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. Accessed April 25, 2024. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. iRhythm Technologies, 2025. iRhythm Technologies, 2024. www.nhlbi.nih.gov.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. Be sure to check your qualifying status using the QPP Participation Status Tool.

Medicare 52

Medicare CMS Document Technology 52

DAIC

JUNE 12, 2024

Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries.

Stents 105

Stents Stent Anatomy Ultrasound 105

GEMMS

APRIL 8, 2024

Below, we will explore the 2024 changes to MIPS and how interoperability features in EHR software can revolutionize how cardiology providers approach MIPS reporting changes. Additionally, the 2024 final rule retains the methodology for measuring scores and achieving points with no notable alterations. What is MIPS?

Medicare 52

Medicare Innovation Medicaid Patient Care 52

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

JUNE 4, 2024

In January 2024, the Centers for Medicare and Medicaid Services (CMS) began requiring health care organizations to screen for five social factors: Food insecurity Interpersonal safety Housing insecurity Transportation Utilities The purpose of these screenings is to encourage engagement of community-based organizations with resources to address SDOH.

Stroke 115

Stroke Strokes Innovation Research 115

DAIC

JANUARY 3, 2024

milla1cf Wed, 01/03/2024 - 11:45 January 3, 2024 — HeartFlow, Inc. , 3 HeartFlow’s FFR CT Analysis is covered by Medicare and for >99% of commercially insured lives. This accomplishment is a testament to HeartFlow's dedication to driving a new standard of care and marks an important milestone for the company.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

MARCH 5, 2024

HIMSS 2024 will be held March 11-15 in Orlando, FL. Andrea Fletcher , Chief Digital Strategy Officer and Director of the Digital Service at Centers for Medicare and Medicaid Services ( CMS ) will present, “ Teaching the Elephant to Dance: Digital Transformation in the United States ” on March 13 in an afternoon education session.

CMS 52

CMS COVID-19 Medicare Education 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4124585-A4124585, November 12, 2024. Using Current Procedural Technology codes, the first 150 patients that underwent carotid ultrasound in 2021 were identified. Introduction/Background:Low-value care is defined as care where harms or costs outweigh patient benefits.

Ultrasound 40

Ultrasound Medicare Technology Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP105-AWP105, February 1, 2024. Introduction:This study evaluates the outcomes of a survivor-centric, navigator-driven, technology-enabled platform supporting survivors (SS) and care partners(CP) in post-stroke recovery.

Outcomes 40

Outcomes Stroke Strokes Quality of Life 40

DAIC

MARCH 14, 2024

The letter noted that the AMA was also pleased with the letter to health care leaders that Secretary Becerra and Acting Secretary Su sent on March 10, 2024. Ensure all Medicare Administrative Contractors (MACs) and health plans are accepting paper claims. Encourage the health information technology community to postpone user fees.

CMS 101

CMS Medicare Medicaid Technology 101

Cardiometabolic Health Congress

JANUARY 19, 2024

Since 1923, technologies have emerged for insulin production, delivery of insulin, and blood glucose monitoring, including insulin pens, insulin pumps, lancets, test strips, and continuous glucose monitoring (CGM)—for those who can afford it. However, we continue to see incremental improvements in the field of insulin therapy.

Diabetes 59

Diabetes Medicare Diet CME 59

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. TCT 2024 4 WHO.

CMS 52

CMS Blood Pressure Medicare Hypertension 52